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Abstract
Introduction: The insulin gene variable number of tandem repeats (INS VNTR) class III allele has been implicated in lower birth weight, 
obesity, and insulin resistance. We assessed its influence on birth weight in the Polish population and on the current body mass and 
metabolic profile in prepubertal children born small for gestational age (SGA). 
Material and methods: DNA for genotyping of INS VNTR was available for 123 subjects born SGA and 132 born appropriate for gestational 
age (AGA). We identified two alleles: class I and class III. Next, in 112 prepubertal (aged: 6.8 ± 1.38 years) SGA children, the auxological 
measurements, fasting serum C-peptide, triglycerides, cholesterol, ghrelin, leptin, adiponectin, resistin, cortisol, and insulin-like growth 
factor type I (IGF-I) concentrations, as well as glucose and insulin during oral glucose tolerance test (OGTT), were assessed and insulin 
resistance indices were calculated. The results were analysed depending on INS VNTR variants. 
Results: The occurrence of individual INS VNTR variants were similar in the SGA and AGA groups. In prepubertal SGA children, we did not 
observe any statistical differences as regards birth weight, body mass, lipids, or adipocytokine concentrations among I/I, I/III, and III/III class 
groups. The concentration of insulin in 120’ of OGTT was significantly higher in class III homozygous than in class I homozygous individuals.
Conclusions: Variant INS VNTR class III was shown not to be associated in any essential way with birth weight in the Polish population. 
Among prepubertal SGA children, the presence of INS VNTR class III is related to higher insulin secretion during OGTT. 
(Endokrynol Pol 2016; 67 (6): 585–591)
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Streszczenie
Wstęp: Sugeruje się, że występowanie allelu klasy III fragmentu różnej liczby tandemowych powtórzeń (VNTR) genu insuliny (INS) przyczynia 
się do niższej masy urodzeniowej oraz rozwoju otyłości i insulinooporności. Autorzy ocenili wpływ tego wariantu na masę urodzeniową 
w populacji polskiej oraz na masę ciała i profil metaboliczny u przeddojrzewaniowych dzieci urodzonych ze zbyt niską masą ciała (SGA). 
Materiały i metody: Oceniono polimorfizm INS VNTR u 123 osób z SGA i 132 urodzonych z prawidłową masą ciała (AGA). Identyfikowa-
no dwa alelle VNTR: klasy I i klasy III. Następnie wyodrębiono grupę 112 przeddojrzewaniowych dzieci z SGA (w wieku 6,8 ± 1,38 lat), 
u których wykonano pomiary auksologiczne oraz oznaczono stężenie: C-peptydu, triglicerydów, cholesterolu, greliny, leptyny, adipo-
nektyny, rezystyny, kortyzolu i insulinopodobnego czynnika wzrostu typu I (IGF-I), jak również oceniono stężenie glukozy i insuliny 
podczas doustnego testu tolernacji glukozy (OGTT). Obliczono wskaźniki insulinooporności. Wyniki przeanalizowano w zależności od 
występowania typu polimorfizmu INS VNTR. 
Wyniki: Częstość występowania poszczególnych wariantów INS VNTR nie różniła się w grupie AGA i SGA. U przeddojrzewaniowych 
dzieci z SGA nie obserwowano istotnych różnic w odniesieniu do ich urodzeniowej masy ciała, aktualnej masy ciała, stężenia lipidów 
i adipocytokin w zależności od występowania klasy I/I, I/III czy III/III. Stężenie insuliny w 120. minucie OGTT było istotnie wyższe 
u homozygotycznych dzieci z klasą III niż u homozygotycznych dzieci z klasą I.
Wnioski: Wariant INS VNTR klasy III nie wydaje się być przyczyną niskiej urodzeniowej masy ciała (SGA) w populacji dzieci polskich. 
Wśród przeddojrzewaniowych dzieci z SGA, obecność klasy III INS VNTR wiąże się z wyższym wydzielaniem insuliny podczas OGTT. 
(Endokrynol Pol 2016; 67 (6): 585–591)
Słowa kluczowe: INS VNTR; niska masa urodzeniowa; dzieci; otyłość; insulinooporność; adipocytokiny
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Introduction 
Approximately 3–10% of children are born small for 
gestational age (SGA). It means that their birth weight 
and/or birth length are below –2.0 standard deviation 
scores (SDS) for the mean value for gestational age 
(GA) [1, 2]. The causes of SGA include environmental 
factors and placental anomalies. However, in some cases 
they remain unexplained. Because familial recurrence 
and parental contribution to SGA have been observed, 
various genetic mutations are taken into consideration 
[3]. SGA individuals are characterised by a higher risk 
of obesity, insulin resistance (IR), and diabetes type 2 
(T2DM) in adulthood [4]. However, we observed that 
certain symptoms can occur as early as in the first dec-
ade of life [5].
Insulin is crucial for both foetus growth and glucose 
metabolism. Variations in the insulin gene variable 
number of tandem repeats (INS VNTR) have been im-
plicated in susceptibility to lower birth weight as well 
as to IR, T2DM, and obesity because it has been shown 
that they are influenced by pancreatic insulin gene 
transcription and altered insulin secretion, both in the 
foetus and the adult [6, 7]. According to the number of 
repeats, the alleles of INS VNTR are divided into: class I 
(with 26–63 repeats), class II (with 64–140 repeats), and 
class III (with 141–209 repeats); however, class II is very 
rare in the Caucasian population [8]. It was proven 
that both in foetal and in adult pancreas, lower insulin 
mRNA expression in INS VNTR class III homozygous 
than in class I homozygous individuals is observed [6, 
7, 9]. However, the potential effect of class III allele on 
birth weight is still controversial [10–18]. On the other 
hand, class III is protective against diabetes mellitus 
type 1 (T1DM) and leads to an overexpression of insu-
lin [19–21]. Thus, it may be responsible for obesity, IR, 
T2DM, and polycystic ovary syndrome (PCOS); how-
ever, the results regarding the influence of INS VNTR 
polymorphism on these disorders, both in the general 
population and in SGA individuals, are divergent [10, 
13, 15, 17, 22–29]. The aim of the study was to verify 
whether INS VNTR class III allele is associated with 
low birth weight in the Polish population and to assess 
the influence of this variant on the current body mass 
index (BMI) as well as on the metabolic and hormonal 
profile in prepubertal SGA children. 
Material and methods
In order to evaluate the incidence of INS VNTR gene 
class III, a genetic analysis was performed in 255 pa-
tients, including 123 (64 girls and 59 boys) subjects born 
SGA and 132 subjects (75 girls and 57 boys) born ap-
propriate for gestational age (AGA). The children were 
qualified as SGA when their birth weight was below 
–2.0 SD for GA and sex, and as AGA when their birth 
weight was between –1.5 and +1.5 SD for GA and sex. 
In order to enrol a group of children with SGA, writ-
ten invitations were posted to the parents of all the chil-
dren with birth weight below 2500 g which were born 
at the Polish Mother ’s Memorial Hospital-Research 
Institute (PMMH-RI) during the period 1999–2003. The 
exclusion criteria were applied to children from twin 
pregnancies, those with congenital abnormalities, and 
those with Silver-Russell syndrome, Turner syndrome, 
and other serious chronic diseases. 
In order to have a group of children with AGA, blood 
samples were collected for genetic tests from children 
diagnosed at the Department of Endocrinology and 
Metabolic Diseases PMMH-RI for various reasons, as 
well as samples of umbilical blood from children born 
during the study at the PMMH-RI. 
Genetic analysis
Genomic DNA was isolated from peripheral blood 
lymphocytes. The method of amplification was ap-
plied with the use of fluorescence-labelled probes, 
specific for allele variants. Fluorescence detection was 
performed by a 7900HT Fast Real-Time PCR System 
(Applied Biosystems, USA). We studied rs689 (also 
called 23HphI), a single nucleotide polymorphism in 
complete linkage disequilibrium with the INS VNTR 
locus, identifying two alleles: A and T. The rs689 A al-
lele is representative of class I, whereas rs689 T allele is 
representative of class III of VNTR [30]. Then the cor-
relation between birth weight (BW) and birth length 
(BL) was analysed with regards to the presence of I/I, 
I/III, and III/III variants. Birth weight and birth length 
were expressed by standard deviation score (SDS) for 
the gestational age and sex of the child (BW SDS and 
BL SDS), following the standards for the population 
of Polish children [31].
In turn, in the group of prepubertal children born 
SGA, we decided to establish the effect of the presence 
of allele class III variants on the occurrence of obesity 
and disturbances in glucose, insulin, C-peptide, lipids, 
and adipocytokines secretion rates. Thus, 112 prepuber-
tal children (57 girls and 55 boys), aged 4.8 to 9.4 years 
(mean: 6.8 ± 1.38 years) were qualified into that part of 
the study. All of them were born small for gestational 
age (birth weight below –2.0 SD for sex and GA). In 
each of the children, anthropometric measurements 
were performed (body height, body mass, and waist 
circumference). Fasting triglycerides, total cholesterol 
and its fractions: HDL-cholesterol and LDL-cholesterol, 
C-peptide, ghrelin, leptin, adiponectin, resistin, cor-
tisol, and IGF-I were assessed. Glucose and insulin 
concentrations were measured at fasting state and 60 
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and 120 minutes after the oral glucose tolerance test 
(OGTT), following glucose administration in the dose of 
1.75 grams of glucose per kilogram of body mass, to 
a maximum dose of 75 g. On the basis of the obtained 
results, height SDS (HSDS), body mass index (BMI), and 
BMI SDS were calculated following the standards for the 
population of Polish children [32]. We also calculated the 
waist-to-height ratio (WHtR), which has recently been 
proposed for visceral obesity assessment in children [33] 
because it accounts for considerable height variations 
among children of the same age. Besides, the insulin 
resistance index (IRI) calculated using HOMA [34] 
and IRI calculated using Belfiore methods [35] were 
applied, according to the following formulas:
IRIHOMA = [(GLU0’/18.5) × INS0’]/22.5, where GLU0’ — 
fasting glucose concentration, expressed in mg/dL, INS0’ 
— fasting insulin concentration, expressed in mIU/L;
IRIBelfiore = 2/{[1/(GLUAUC × INSAUC)] + 1}, where: 
GLUAUC = GLUAUCi/GLUAUCmean, while INSAUC = INSAUCi/ 
/INSAUCmean, where GLUAUCi and INSAUCi — areas under 
respective glucose or insulin concentration curve dur-
ing OGTT in a given patient, while GLUAUCmean and 
INSAUCmean — areas under respective glucose or insulin 
concentration curves during OGTT for an age group 
for our population (those values were calculated in our 
earlier work) [36]. 
The total ghrelin concentration was measured using 
the Millipore RIA kit (Linco Research) with sensitivity 
level: 100-10.000 pg/mL, intra-assay CV: 3.3–10.0%, and 
inter-assay CV: 14.7–17.8%. 
The leptin, adiponectin, and resistin concentrations 
were measured using the Millipore ELISA kit (Linco 
Research). Sensitivity level, the intra-assay CV, and 
inter-assay CV were, respectively: 0.5–100 ng/mL, 1.4–
–4.9%, and 1.3–8.6% for leptin; from 0.78 ng/mL, 7.4%, 
and 2.4–8.4% for adiponectin and from 0.16 ng/mL, 
3.2–7.0%, and 7.1–7.7% for resistin. 
Plasma insulin concentration was measured using 
the DRG ELISA kit; sensitivity level 1.76–100 µIU/mL, 
the intra-assay CV: 1.8–2.6, and inter-assay CV: 2.9–6.0. 
IGF-I was assessed by Immulite, DPC assays; WHO 
NIBSC 1st IRR 87/518 standard was applied, with an ana-
lytical sensitivity of 20 ng/mL, calibration range up to 
1600 ng/mL, intra-assay CV — 3.1–4.3% and inter-assay 
CV — 5.8–8.4%. For comparison of children with differ-
ent age and sex, IGF-I concentrations were expressed 
as IGF-I SDS, according to reference data. 
In the evaluation of the obtained results, ANOVA 
statistical analysis was applied. For some statistical 
comparisons with variant I/I, subjects heterozygous I/III 
and homozygous III/III for the mutation were combined 
and referred to as I/III + III/III. Comparisons between 
genotypes were made on adjusted values using Mann-
Whitney U test (I/I vs. I/III + III/III) or Kruskal-Wallis 
test for the three genotype groups. A p value < 0.05 
was considered to be statistically significant.
Results
We did not find any statistical differences in the oc-
currence of polymorphisms in the groups of children 
with SGA and AGA (Table I). The frequency distribution 
did not deviate from the Hardy-Weinberg equilibrium 
c2 = 1.16; p = 0.71 for SGA and c2 = 0.59; p = 0.55 
for AGA. 
In the analysed group of prepubertal SGA children 
we did not observe any statistical differences for birth 
weight and birth length among individual variants of 
INS VNTR gene groups (Table II). 
In children with allele class III (I/III and III/III) group, 
the values of BMI and WHtR were higher than I/I but 
the differences were only on the border of statisti-
cal significance (Table III). In turn, we observed that 
triglyceride concentrations were significantly higher 
in the I/III+III/III group than in the I/I group, while 
we did not find any differences as regards cholesterol 
and its fractions between groups (Table IV). The cor-
relation analysis showed that in the examined group 
of SGA children, triglycerides positively correlated 
with WHtR (r = +0.31, p < 0.05), BMI SDS (r = +0.32, 
p < 0.05), fasting insulin concentration (r = +0.39, 
p < 0.05), insulin at 60’ (r = +0.22, p < 0.05), insulin at 120’ 
(r = +0.26, p < 0.05), IRIHOMA (r = +0.37, p < 0.05), IRIBelfiore  
(r = +0.21, p < 0.05), and leptin concentration (r = +0.39, 
p < 0.05). 
We did not observe any statistical differences as 
regarded glucose concentrations among the groups. 
Nevertheless, we found that the fasting insulin concen-
tration and IRIHOMA was significantly lower in the III/III 
group than in the heterozygous I/III group, while insu-
Table I. The incidence of individual variants (I/I, I/III, and 
III/III) of INS VNTR gene in the groups of children born 
small for gestational age or born appropriate for gestational 
age (SGA or AGA)
Tabela I. Częstość występowania poszczególnych wariantów 
(I/I, I/III i III/III) VNTR genu INS w grupie dzieci urodzonych 
z niską i z prawidłową masą ciała (SGA i AGA)
INS VNTR variant I/I I/III III/III
SGA = 123 68 (55.3%) 46 (37.4%) 9 (7.3%)
AGA = 132 71 (53.8%) 51 (38.6%) 10 (7.6%)
p = 0.33 p = 0.39 p = 0.48
SGA — small for gestational age; AGA — appropriate for gestational age. The 
incidence distribution did not deviate from the Hardy-Weinberg equilibrium  
c2 = 1.16; p = 0.71 for SGA and c2 = 0.59; p = 0.55 for AGA. Odds ratio for  
III/III genotype is 0.88.
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lin concentrations at other time points were similar in 
individual analysed groups. However, the comparison 
of groups I/III and III/III together shows that in children 
with allele class III, the concentration of insulin in 120’ 
of OGTT is significantly higher than in children with 
both class I alleles (Table V). 
Table II. Perinatal data (mean ± SD) in individual variants of INS VNTR gene in the analysed group of prepubertal SGA children
Tabela II. Dane okołoporodowe (średnia ± SD) w zależności od rodzaju wariantu INS VNTR w analizowanej grupie 
przeddojrzewaniowych dzieci z SGA
INS VNTR 
variant
I/I I/III III/III I/I vs. I/III vs. III/III (I/III + III/III) I/I vs. I/III + III/III
n = 61 42 9 *P value 51 **P value
Age (years) 6.9 ± 1.33 6.87 ± 1.43 6.8 ± 1.74 0.979535 6.85 ± 1.47 0.874067
GA (week) 38.34 ± 1.38 38.29 ± 1.31 37.89 ± 0.78 0.627259 38.22 ± 1.24 0.607538
BL [cm] 55 ± 17.11 53 ± 11.88 49.38 ± 2.62 0.54682 52.38 ± 10.94 0.370015
BL SDS –0.15 ± 1.59 0.42 ± 1.49 –0.06 ± 1.36 0.231555 0.34 ± 1.46 0.129595
BW [g] 2318.2 ± 312.41 2314.5 ± 222.80 2383.3 ± 134.63 0.778081 2326.67 ± 210.49 0.869408
BW SDS –2.02 ± 0.59 –2.11 ± 0.53 –2.04 ± 0.37 0.456618 –2.09 ± 0.52 0.717246
*p — according to Kruskal-Wallis test, **p — according to Mann-Whitney U test. GA — gestational age, BW — birth weight, BW SDS — birth weight standard 
deviation score, BL — birth length; BL SDS — birth length standard deviation score
Table III. Auxological data (mean ± SD) in individual variants of INS VNTR gene in the analysed group of prepubertal SGA 
children
Tabela III. Dane auksologiczne (średnia ± SD) w zależności od rodzaju wariantu INS VNTR w analizowanej grupie 
przeddojrzewaniowych dzieci z SGA
INS VNTR 
variant
I/I I/III III/III I/I vs. I/III vs. III/III I/III + III/III I/I vs. I/III + III/III
n = 61 42 9 *P value 51 **P value
Height [cm] 122.58 ± 10.79 124.03 ± 12.06 122.03 ± 14.12 0.790229 123.68 ± 12.32 0.616653
H SDS 0.16 ± 1.06 0.41 ± 1.18 0.07 ± 1.09 0.4697 0.35 ± 1.16 0.364538
Body mass [kg] 23.86 ± 6.45 26.07 ± 8.81 25.91 ± 10.74 0.338907 26.04 ± 9.06 0.140630
BMI [kg/m2] 15.61 ± 2.18 16.47 ± 2.61 16.65 ± 3.31 0.156875 16.50 ± 2.71 0.055113
BMI SDS –0.1 ± 0.95 0.18 ± 1.01 0.07 ± 1.28 0.361165 0.16 ± 1.05 0.163606
Waist [cm] 56.45 ± 7.01 58.93 ± 9.47 59.39 ± 12.70 0.290574 59.01 ± 9.97 0.116657
WHtR 0.46 ± 0.04 0.47 ± 0.05 0.48 ± 0.06 0.18045 0.48 ± 0.05 0.075773
*p — according to Kruskal-Wallis test, **p — according to Mann-Whitney U test. H SDS — height standard deviation score, BMI — body mass index, BMI SDS — 
body mass index standard deviation score, WHtR — waist-to-height ratio
Table IV. Triglycerides, total cholesterol, or HDL-cholesterol and LDL-cholesterol fractions concentrations (mean ± SD) in 
individual variants of INS VNTR gene in the analysed group of prepubertal SGA children
Tabela IV. Stężenie triglicerydów, cholestrolu całkowitego i jego frakcji HDL i LDL (średnia ± SD) w zależności od rodzaju 
wariantu INS VNTR w analizowanej grupie przeddojrzewaniowych dzieci z SGA
INS VNTR variant I/I I/III III/III I/I vs. I/III vs. III/III I/III + III/III I/I vs. I/III + III/III
n = 61 42 9 *P value 51 **P value
Total cholesterol [mg/dL] 173.72 ± 25.85 170.71 ± 27.81 167.44 ± 36.68 0.750451 170.14 ± 29.17 0.492183
Triglycerides [mg/dL] 66.25 ± 27.40a 79.76 ± 36.33 76.22 ± 42.06 0.108695 79.14 ± 36.98a 0.036594
HDL-cholesterol [mg/dL] 60.11 ± 14.26 57.95 ± 15.69 58.67 ± 11.87 0.758787 58.08 ± 14.99 0.463705
LDL-cholesterol [mg/dL] 99.66 ± 20.54 98.24 ± 26.69 94.67 ± 36.00 0.837841 97.61 ± 28.17 0.657896
HDL/total cholesterol ratio 0.35 ± 0.09 0.35 ± 0.10 0.36 ± 0.11 0.856165 0.35 ± 0.10 0.755334
*p — according to Kruskal-Wallis test, **p — according to Mann-Whitney U test, a — p < 0.05
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Among the analysed group of SGA children, we 
did not find any differences as regards ghrelin, leptin, 
adiponectin, resistin, C-peptide, IGF-I, or cortisol con-
centration (Table VI). 
Discussion
In our study, we found that the incidence of individual 
INS VNTR variants was similar in children born AGA 
and SGA, and the distribution of the alleles in both 
groups was analogous to the testing of large Cauca-
sian populations [14, 17]. The frequency distribution 
in the AGA and in SGA groups did not deviate from 
the Hardy-Weinberg equilibrium; the odds ratio for 
genotypes III/III in SGA was 0.88. 
Among SGA children, similarly to results provided 
by others [14–18], we did not find any relationship as 
regards the examined variants of INS VNTR and birth 
weight or birth length. Although Lindsay et al. [10] 
have reported that the class III allele is associated with 
a reduction of birth weight, we should be aware that the 
analysis was performed among Pima Indians, in whom 
high incidence of obesity, IR, and T2DM is observed, 
and the distribution of birth weight may be associated 
with these maternal factors.
Next, we analysed the influence of INS VNTR class 
IIII on auxological and hormonal parameters in a large 
group of prepubertal SGA children after the catch-up of 
growth phenomenon. There are few studies concern-
ing the prevalence of obesity and IR depending on the 
Table V. Glucose and insulin concentrations during OGTT and the calculated values of IRIs (mean ± SD) in individual variants 
of INS VNTR gene in the analysed group of prepubertal SGA children
Tabela V. Stężenie glukozy i insuliny podczas OGTT oraz wartości wskaźników insulinooporności (średnia ± SD) w zależności 
od rodzaju wariantu INS VNTR w analizowanej grupie przeddojrzewaniowych dzieci z SGA
INS VNTR variant I/I I/III III/III I/I vs. I/III vs. III/III I/III + III/III I/I vs. I/III + III/III
n = 61 42 9 *P value 51 **P value
Glucose 0’[mg/dL] 81.39 ± 8.23 82.81 ± 7.25 79.78 ± 6.04 0.474 82.27 ± 7.09 0.549
Glucose 60’[mg/dL] 113.77 ± 34.67 105.55 ± 25.21 122.67 ± 20.66 0.213 108.57 ± 25.16 0.375
Glucose 120’[mg/dL] 102.55 ± 20.88 107.07 ± 18.26 106.11 ± 13.14 0.499 106.90 ± 17.35 0.240
Insulin 0’[uIU/mL] 3.68 ± 2.34 4.56 ± 2.95a 2.58 ± 2.29a 0.026 4.21 ± 2.92 0.286
Insulin 60’[uIU/mL] 20.19 ± 17.05 21.97 ± 20.60 23.64 ± 22.92 0.823 22.27 ± 20.80 0.564
insulin 120’[uIU/mL] 17.23 ± 10.77c 23.37 ± 17.81 20.45 ± 17.03 0.107 22.85 ± 17.54c 0.041
IRIHOMA 0.74 ± 0.51 0.95 ± 0.63
b 0.52 ± 0.48b 0.0376 0.87 ± 0.62 0.212
IRIBELFIORE 0.86 ± 0.30 0.89 ± 0.37 0.9 ± 0.38 0.580 0.89 ± 0.37 0.679
C-peptide [ng/mL] 2.37 ± 1.31 2.41 ± 1.26 2.12 ± 1.49 0.835 2.36 ± 1.29 0.964
*p – according to Kruskal-Wallis test, **p – according to Mann-Whitney U test. a,b,c — p < 0.05
Table VI. Ghrelin, IGF-I, cortisol, leptin, resistin, and adiponectin concentrations (mean ± SD) in individual variants of INS 
VNTR gene in the analysed group of prepubertal SGA children
Tabela VI. Stężenie greliny, IGF-I, kortyzolu, leptyny, rezystyny i adiponektyny (średnia ± SD) w zależności od rodzaju 
wariantu INS VNTR w analizowanej grupie przeddojrzewaniowych dzieci z SGA
INS VNTR variant I/I I/III III/III I/I vs. I/III vs. III/III I/III + III/III I/I vs. I/III + III/III
n = 61 42 9 *P value 51 **P value
Ghrelin [pg/mL] 2819.1 ± 2316.8 2231.8 ± 1301.8 2575.5 ± 2526.7 0.398 2299.1 ± 1584.2 0.199
IGF-I [ng/mL] 199.01 ± 67.46 204.35 ± 93.02 175.6 ± 68.59 0.608 199.07 ± 89.11 0.997
IGF-I SDS 0.67 ± 0.72 0.7 ± 0.82 0.52 ± 0.67 0.811 0.67 ± 0.79 0.998
Cortisol [µg/dL] 11.88 ± 5.76 12.27 ± 5.36 14.06 ± 7.47 0.571 12.61 ± 5.76 0.517
Leptin [ng/mL] 6.39 ± 5.79 7.9 ± 9.37 6.84 ± 8.38 0.635 7.69 ± 9.10 0.381
Resistin [ng/mL] 9.92 ± 4.42 10.24 ± 3.52 11.21 ± 4.61 0.676 10.43 ± 3.72 0.534
Adinopectin [ng/mL] 25.41 ± 12.07 25.99 ± 12.21 23.29 ± 12.03 0.837092 25.45 ± 12.09 0.987
*p — according to Kruskal-Wallis test, **p — according to Mann-Whitney U test
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discussed variants in such a sublime population as chil-
dren with SGA [15, 29]. Vu-Hong et al. [15] and Coletta 
et al. [29], similarly to us, did not find any significant 
differences between BMI and INS VNTR variants in 
SGA children.
In a general population, other authors also did not 
support associations between INS VNTR and body 
composition in childhood [25–28]. 
Generally, higher levels of insulin concentration 
and IRIHOMA in SGA than AGA children are reported, 
especially in those of SGA in whom rapid weight gain 
in the first years of life was observed [37]. The authors 
suspected that it may be a risk factor for the develop-
ment of IR and T2DM in later life. However, not all 
reports confirm this relationship [38]. In our study, we 
found that prepubertal SGA children with homozygous 
III/III had lower fasting insulin concentration and lower 
IRIHOMA than children from other groups, whereas chil-
dren with at least one allele T (class III), i.e. III/III or I/III, 
tended to have higher secretion of insulin at 120’ of 
OGTT than SGA children with homozygous I/I. 
Vu-Hong et al. [15] reported that the INS VNTR 
class III allele was associated with higher fasting insulin 
concentration and a lower quantitative insulin sensitiv-
ity check index (QUICKY) in SGA subjects, but not in 
AGA once; however, the study was performed among 
young adults born SGA, with mean age 22 years. Other 
authors demonstrated that INS VNTR genotypes in the 
general population were not associated with fasting 
insulin secretion and also reported the lack of support 
for a role of INS VNTR in IR and T2DM [17, 23, 27]. In 
large-scale studies involving Danish Caucasians, young 
healthy subjects who were carriers of the INS VNTR 
class III/III had significantly decreased acute serum 
insulin and C-peptide responses during an IVGTT 
when compared with class I/I and heterozygous carri-
ers. However, no impact of the class III allele on serum 
insulin and C-peptide responses to an oral glucose load 
could be demonstrated in middle-aged subjects [28].
Some researchers assessed insulin levels during 
OGTT in individual variants of INS VNTR in a group 
of obese children [39, 40]. They observed significantly 
higher insulin secretion in I/I obese children versus III 
carriers. 
Thus, the relationship between the variants of INS 
VNTR and insulin concentration secretion and IR re-
mains unclear. 
We are aware of the limitations resulting from the 
cohort size, so further investigations are needed to 
elucidate the issue in question. 
Low fasting insulin levels in homozygous III/III chil-
dren is not surprising in the sense that class III alleles 
are associated with lower levels of insulin mRNA in 
vivo [7]. In turn, high levels of insulin at the 120th min-
ute of OGTT in class III individuals indicates a greater 
functional reserve of beta cells in response to hyper-
glycaemic stimuli. Similar results obtained in a patient 
with familial background of T1DM were presented by 
Fendler et al. [21] Moreover, Fendler et al. [19] found 
that class I homozygosity is a significant risk factor of 
DM1 and acts independently from HLA haplotype in 
the actual risk of diabetes in children. Cejkova et al. 
[41] confirmed that the simultaneous effect of HLA 
and INS VNTR genotypes predispose to an increased 
risk of T1DM, LADA, or T2DM development. Similar 
conclusions regarding INS VNTR were presented by 
Zhang et al. [42]. In our study, apart from the insulin 
concentration, we also measured the concentration of 
C-peptide, which did not differ depending on the indi-
vidual variant in the group of children analysed by us. 
Also, we did not find any differences in IRIBELFIORE 
among individual variants of INS VNTR gene. Thus, 
even if the concentration of insulin is higher at the 120th 
minute of OGTT, it does not indicate the presence of 
IR. However, nutritional interventions may prevent IR 
in the future. 
In our earlier work [43] we found that in prepu-
bertal SGA children with catch-up, higher ghrelin and 
higher IGF-I concentration were observed than in SGA 
children without catch-up. Thus, we also analysed the 
differences in the concentrations of these hormones, 
depending on the genotypes. We should be aware 
that insulin concentration is negatively correlated with 
ghrelin concentration, and that insulin is permissive 
in nature for the production of IGF-I. However, in the 
group of children examined by us, we did not identify 
any significant differences in this respect. 
In conclusion, variant INS VNTR class III was shown 
not to be associated in any essential way with birth 
weight in the Polish population. However, our data sup-
port the possible role of this gene in the development 
of insulin resistance in the later life of SGA individuals. 
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